Neuland Laboratories Current ratio
What is the Current ratio of Neuland Laboratories?
The Current ratio of Neuland Laboratories Limited is 1.44
What is the definition of Current ratio?
Current ratio is a liquidity ratio that measures whether or not a company has enough resources to meet its short-term obligations.
mrq (most recent quarter)
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with current ratio similar to Neuland Laboratories
- Premier Polyfilm has Current ratio of 1.44
- Flux Power has Current ratio of 1.44
- Alten SA has Current ratio of 1.44
- Flux Power has Current ratio of 1.44
- CIMC-TianDa has Current ratio of 1.44
- Banswara Syntex has Current ratio of 1.44
- Neuland Laboratories has Current ratio of 1.44
- Grid Metals has Current ratio of 1.44
- Core Economy Investment has Current ratio of 1.44
- Kam Hing International has Current ratio of 1.44
- Sasol Ltd has Current ratio of 1.44
- Hindoostan Mills has Current ratio of 1.44
- Adrad has Current ratio of 1.44